April 19, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a generic version of metoprolol succinate extended-release tablets. The beta-blocker is used to treat angina, heart failure and high blood pressure.
April 14, 2010 – An antibacterial wrap for implanted pacemakers and defibrillators released this week is designed to provide protection against infections. The AigisRx Flat delivers the antimicrobial agents rifampin and minocycline.
April 14, 2010 – Two external pacemakers were launched in Europe today that offer an intuitive design for safer usage in emergencies and temporary patient care.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 14, 2010 – The Mount Sinai Medical Center in New York has become the first facility in the United States to commercially use a new cardiac nuclear imaging system that drastically reduces imaging time and radiation exposure.
April 14, 2010 - When college football’s elite enter Radio City Music Hall April 22 for the 2010 National Football League (NFL) draft, it will be after much public analysis of their stats and accomplishments. Also important to a player’s prospect of being drafted is the outcome of diagnostic tests including X-rays, magnetic resonance imaging (MRI) and cardiac evaluations.
April 13, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a combined electrocardiogram (ECG) Holter and ambulatory blood pressure monitoring recorder and software analysis system.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 13, 2010 – A catheter designed to deliver embolic materials and radiopaque media to selected sites in visceral vascular territories recently gained FDA clearance. The Gandras Visci-G is a 5 French, 75 cm catheter with a primary curve and a flexible 1 cm tip, making it useful for precise and stable placement in renal, mesenteric or abdominal catheterization procedures.
April 13, 2010 – More than 300 patients in Europe have been enrolled in a real-world study to assess the effectiveness of a coronary bifurcation stent. Enrollment was completed last week in E-Tryton 150 and E-Tryton Benelux, two European registry studies evaluating the Tryton Side Branch Stent System for the treatment of atherosclerotic lesions in the side branch at the site of a bifurcation.
April 13, 2010 – Obstructive sleep apnea is associated with an increased risk of stroke in middle-aged and older adults, especially men, according to new results from a landmark study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Overall, sleep apnea more than doubles the risk of stroke in men.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
April 9, 2010 – The first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new stent graft system to treat abdominal aortic aneurisms (AAA).
April 9, 2010 – A survey of physicians by Majestic Research found that Boston Scientific’s March 15 decision to withdraw from the implantable cardioverter defibrillator (ICD) market will have a meaningful, long-term impact on the implantable electrophysiology device market.
April 9, 2010 – A preclinical study shows the action of a toll-like receptor (TLR) antagonist helps reduce atherosclerosis in mice.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
April 7, 2010 – A medical manufacturer pleaded guilty Monday to criminal violations for improper reporting of short-circuit failures of three models of its implantable cardioverter defibrillators (ICDs), the Justice Department announced. The company also agreed to pay more than $296 million in damages.
April 7, 2010 – The U.S. Food and Drug Administration (FDA) recently sent a warning letter to Edwards Lifesciences Corp. for late reporting of adverse events with its medical devices.
April 7, 2010 – A study concludes ventilator efficiency (VE/VCO2 slope) is more accurate than the current listing criteria for heart transplantation in identifying patients likely to derive a survival benefit from such intervention. The results were recently published in Circulation Heart Failure, a journal of the American Heart Association.